Stock research
ASND — ASCENDIS PHARMA A/S
ASND is reported by 5 tracked managers with $229.6M in visible reported value. This page connects ownership breadth, filing activity, and price context.
Stock research evidence
The latest visible filing snapshot is 2026 Q2. Values come from reported manager holdings; prices and 52-week context come from the latest available market quote.
- Tracked holders
- 5
- Reported value
- $229.6M
- Ownership breadth
- Not available
- Current price
- $264
Top reported managers
These managers have the largest visible reported positions in ASND. Portfolio weight is measured within each manager's latest visible filing.
- John Overdeck / David Siegel0.1% of reported portfolio · $81.6M · Buy · Filed Aug 14, 2026
- Israel Englander0% of reported portfolio · $71.1M · Filed Aug 14, 2026
- Ken Griffin0% of reported portfolio · $36.8M · Buy · Filed Aug 14, 2026
- Jim Simons0% of reported portfolio · $31.9M · Buy · Filed Aug 13, 2026
- David Shaw0% of reported portfolio · $8.2M · Buy · Filed Aug 14, 2026
Continue the research
Review the manager roster, compare this company with the most widely held stocks, or browse transparent screens built from the same filing-backed data.